BioChaperone Pramlintide Insulin

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameBioChaperone Pramlintide Insulin
Drug Alias NameBC-Pram-Ins
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAmylin receptor agonistsInsulin receptor agonistsInsulin ligand
TargetsInsulin receptorAmylin Receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFrance
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAdocia
China Registration ClassN/A

Develop Information

Active CompaniesAdocia
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A